US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

112 deals · US$144bndisclosed · Biotech · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
2026 AttaiBeckley –Eli Lilly and CompanyAcquisitionAnnounced3,800.0Biotech+2 Moelis & Company (sell-side)
2026 FireFly Biologics –J&JAcquisitionAnnounced1,000.0Biotech+1 Centerview Partners (sell-side)
Dec 2025 Dynavax Technologies –SanofiAcquisitionAnnounced2,200.0Biotech+1 Centerview Partners (sell-side)Goldman Sachs (sell-side)Cooley (sell-side)Weil, Gotshal & Manges (buy-side)
Dec 2025 Amicus Therapeutics –BioMarinAcquisitionAnnounced4,800.0Biotech+2 Centerview Partners (sell-side)Goldman Sachs (sell-side)Kirkland & Ellis (sell-side)Morgan Stanley (buy-side)Jones Day (buy-side)
Dec 2025 Generation Bio Co. –XRA 7 Corp.AcquisitionAnnounced–Biotech+1 TD Securities (sell-side)WilmerHale (sell-side)Gibson Dunn (buy-side)
Dec 2025 MindWave Innovations –Apimeds Pharmaceuticals USMergerCompleted–Biotech+1 Duane Morris (sell-side)Nelson Mullins Riley & Scarborough (buy-side)
Nov 2025 Aptose Biosciences –HS North AmericaAcquisitionAnnounced–Biotech+2 Locust Walk (sell-side)Stikeman Elliott (buy-side)
Oct 2025 Avidity Biosciences –NovartisAcquisitionAnnounced11,000.0Biotech+2 Goldman Sachs (sell-side)Barclays (sell-side)Kirkland & Ellis (sell-side)Covington & Burling (buy-side)Freshfields (buy-side)Gordon Dyal & Co. (buy-side)
Oct 2025 Astria Therapeutics –BioCryst PharmaceuticalsAcquisitionCompleted700.0Biotech+2 Evercore (sell-side)Sidley Austin (sell-side)BofA Securities (buy-side)Covington & Burling (buy-side)
Jul 2025 DiamiR Biosciences Corp. –Aptorum GroupMergerCompleted–Diagnostics+1 H.C. Wainwright & Co. (sell-side)
Feb 2025 Instinct Bio Technical Company –Relativity Acquisition SponsorMergerPending225.0Biotech Hunter Taubman Fischer & Li (sell-side)Chardan (sell-side)Loeb & Loeb (buy-side)Ogier (buy-side)
– Telomir Pharmaceuticals ––MergerAnnounced47.1Biotech+1

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built